[Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature].
The aim of this systematic review was to evaluate the effectiveness of ginkgo biloba in the treatment of intermittent claudication. A Medline-search identified ten controlled trials on the subject. These were heterogeneous in all respects and, with only few exceptions, of poor methodological quality. All the studies implied that ginkgo biloba is an effective therapy for intermittent claudication. This hypothesis should be confirmed in further trials employing meticulous methodology. Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.
Ernst
E
E
Postgraduate Medical School, University of Exeter/UK.
D002986:Clinical Trials as Topic; D004224:Diterpenes; D004311:Double-Blind Method; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D046934:Ginkgolides; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D007783:Lactones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D004224:Diterpenes; D005343:Fibrinolytic Agents; D046934:Ginkgolides; D007783:Lactones; C045856:ginkgolide B
Ginkgo biloba in der Behandlung der Claudicatio intermittens. Eine systematische Recherche anhand kontrollierter Studien in der Literatur.